tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HAE Stock Latest News

Haemonetics price target raised to $90 from $75 at Mizuho
The FlyHaemonetics price target raised to $90 from $75 at Mizuho
23d ago
HAE
Haemonetics price target raised to $99 from $87 at Baird
PremiumThe Fly
Haemonetics price target raised to $99 from $87 at Baird
25d ago
HAE
Haemonetics downgraded to Hold from Buy at Needham
PremiumThe Fly
Haemonetics downgraded to Hold from Buy at Needham
25d ago
HAE
Haemonetics price target raised to $74 from $62 at JPMorgan
PremiumThe Fly
Haemonetics price target raised to $74 from $62 at JPMorgan
28d ago
HAE
Haemonetics downgraded to Neutral from Buy at Citi
PremiumThe Fly
Haemonetics downgraded to Neutral from Buy at Citi
29d ago
HAE
Haemonetics price target raised to $90 from $75 at BofA
PremiumThe FlyHaemonetics price target raised to $90 from $75 at BofA
1M ago
HAE
Haemonetics price target raised to $75 from $65 at Mizuho
Premium
The Fly
Haemonetics price target raised to $75 from $65 at Mizuho
2M ago
HAE
Haemonetics Reports Positive Earnings Call with Growth Highlights
Premium
Company Announcements
Haemonetics Reports Positive Earnings Call with Growth Highlights
2M ago
HAE
Haemonetics upgraded to Neutral from Underperform at BofA
PremiumThe Fly
Haemonetics upgraded to Neutral from Underperform at BofA
2M ago
HAE
Haemonetics price target raised to $90 from $86 at Barrington
PremiumThe Fly
Haemonetics price target raised to $90 from $86 at Barrington
2M ago
HAE
Haemonetics price target raised to $82 from $65 at Baird
PremiumThe Fly
Haemonetics price target raised to $82 from $65 at Baird
2M ago
HAE
Haemonetics Reports Improved Profitability Amid Revenue Decline
PremiumCompany Announcements
Haemonetics Reports Improved Profitability Amid Revenue Decline
2M ago
HAE
Haemonetics: Strong Financial Performance and Strategic Adjustments Drive Buy Rating
PremiumRatingsHaemonetics: Strong Financial Performance and Strategic Adjustments Drive Buy Rating
2M ago
HAE
Haemonetics price target raised to $88 from $85 at BTIG
Premium
The Fly
Haemonetics price target raised to $88 from $85 at BTIG
2M ago
HAE
Haemonetics rises 26.1%
Premium
The Fly
Haemonetics rises 26.1%
2M ago
HAE
Haemonetics narrows FY26 adjusted EPS view to $4.80-$5.00 from $4.70-$5.00
PremiumThe Fly
Haemonetics narrows FY26 adjusted EPS view to $4.80-$5.00 from $4.70-$5.00
2M ago
HAE
Haemonetics reports Q2 adjusted EPS $1.27, consensus $1.11
PremiumThe Fly
Haemonetics reports Q2 adjusted EPS $1.27, consensus $1.11
2M ago
HAE
Haemonetics (HAE) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Haemonetics (HAE) Q2 Earnings Cheat Sheet
2M ago
HAE
Haemonetics: Strategic Adjustments and Growth Potential Justify Buy Rating Despite Revenue Challenges
PremiumRatings
Haemonetics: Strategic Adjustments and Growth Potential Justify Buy Rating Despite Revenue Challenges
3M ago
HAE
Haemonetics price target lowered to $64 from $78 at Citi
PremiumThe FlyHaemonetics price target lowered to $64 from $78 at Citi
3M ago
HAE
Haemonetics Poised for Recovery and Growth: Buy Rating Affirmed Amid Strategic Actions and Strong Segment Performance
Premium
Ratings
Haemonetics Poised for Recovery and Growth: Buy Rating Affirmed Amid Strategic Actions and Strong Segment Performance
4M ago
HAE
Haemonetics’ Earnings Call: Growth Amid Challenges
Premium
Company Announcements
Haemonetics’ Earnings Call: Growth Amid Challenges
5M ago
HAE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >